v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Operating activities:    
Net loss $ (3,817) $ (412)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 2,963 4,668
Bad debt expense 28 975
Stock-based compensation expense 12,065 11,012
Amortization of operating lease right-of-use assets 2,110 2,293
Other, net 366 100
Changes in operating assets and liabilities:    
Accounts receivable 54,316 50,614
Prepaid expenses and other current assets (660) (1,657)
Costs to obtain revenue contracts 4,270 3,329
Other long term assets 80 1,094
Accounts payable, accrued expenses and other current liabilities (4,028) (15,047)
Unearned revenue (26,697) (27,337)
Operating lease liabilities (2,847) (2,904)
Other long term liabilities 160 16
Net cash provided by operating activities 38,309 26,744
Investing activities:    
Capital expenditures (647) (944)
Net cash used in investing activities (647) (944)
Financing activities:    
Proceeds from exercise of stock options 283 7,271
Repurchase of common stock 0 (4,583)
Payments for taxes related to net share settlement of stock-based compensation awards (2,039) (3,237)
Payments of deferred financing costs (338) (64)
Proceeds, net from employee stock purchase plan withholdings 920 925
Net cash (used in) provided by financing activities (1,174) 312
Effect of exchange rate changes on cash and cash equivalents (558) 524
Net increase in cash and cash equivalents 35,930 26,636
Cash and cash equivalents at beginning of period 210,184 190,214
Cash and cash equivalents at end of period $ 246,114 $ 216,850

Source

HTML PDF
ZIP